A seed falling through a planter has a very short commute. It leaves the meter, travels down a tube, meets the earth, and disappears. Inflexion Point Technologies built a company around that fleeting trip. Its machine, the Prescriptive On-Planter Seed Treater, or POP-ST, introduces a measured treatment after the seed enters the planter and before it reaches the soil. The timing is the product.
That sounds like a small adjustment to a familiar farm task. It is more disruptive than it first appears. Seed treatment has traditionally been selected and applied upstream, often before a bag reaches the farm. The choice is fixed across the field. But fields are mosaics: soil, moisture, disease pressure, yield history and pest risk can change from one management zone to the next. POP-ST turns treatment into another precision-agriculture variable, like seeding rate or fertilizer.
The problem hiding inside the seed bag
Conventional treatment remains useful: it protects seed, simplifies handling and arrives ready to plant. Its weakness is flexibility. There is only so much material that can coat a seed, and a treatment selected months earlier cannot respond to a wet pocket, a disease-prone zone or a patch where the expected payoff is low. Biological products add another wrinkle. Some living or delicate formulations are sensitive to storage, mixing and the long interval between application and planting.
The common alternative is in-furrow application, which places material into the trench around the seed. That can be agronomically sound, but it is not the same as coating the seed itself. More carrier and product may be needed to cover the furrow and create contact. IPT's pitch is narrower: put the chosen substance directly onto the seed at the latest practical moment, and change the recipe while the planter crosses the field.
The patent behind that sequence is unusually important for a company of this size. U.S. Patent No. 12,102,027 describes selecting a substance and amount using field or market conditions, then individually applying the desired amount to seed before planting. The listed conditions range from soil and moisture to pests, GPS position and planting practices. In 2025, Syngenta sought post-grant review. The Patent Trial and Appeal Board declined to institute it, finding the petitioner had not met the required threshold. The decision did not turn IPT into a giant, but it left a core commercial asset intact.
“POP-ST was built to expand farmer choice and unlock the next class of seed treatments.”Nick Iwig, CEO and co-founder
A product built out of partnerships
IPT was formed in 2014 in Iowa's agricultural corridor. Co-founders Nick Iwig and Steve Smith brought an odd but useful pairing. Iwig had worked across crop production, seed-treatment sales, soybean strategy and business development. Smith had negotiated agricultural trait licenses after beginning his career in patent litigation. The broader team added planter engineering, farming and startup law. This was not a group likely to confuse a clean patent drawing with a field-ready machine.
Their commercialization method is worth studying. Instead of recreating an equipment industry inside a small company, IPT assembled a chain of specialists. ALMACO, known for seed-research equipment, helped optimize the final product and received preferred licensing terms in the research-planter market. Beck's became a field-trial partner. Biological companies joined 2022 trials. Aginnovation later combined its seed-enhancement work with IPT's delivery technology in Seed Edge Ag, a joint venture focused on high-value vegetables and specialty crops.
The newer TeeJet relationship addresses scale. TeeJet supplies electronics, controllers and decades of precision-application experience. The partners describe a modular system that can be fitted to new or existing planters across makes and ages. For a farmer, that matters: an upgrade has a much easier adoption path than a demand to replace the machine already in the shed.
“Gives farmers a new tool to turn data into decisions at the seed level.”Doug Gamm, TeeJet Technologies
The business behind the droplets
This is enterprise agricultural technology, not a consumer gadget. The likely buyers and users are growers, research programs, seed businesses, biological-input developers and equipment manufacturers. The commercial package can include retrofit hardware, control software, application components, partner treatments, installation and support. Licensing allows the patented method to travel through established equipment channels. OEM integration offers a second path, putting the capability into a planter before it reaches the farm.
That makes the true product larger than the applicator. POP-ST is also a route to market for inputs that struggle inside conventional treatment channels. A biological developer can test a product fresh, at a chosen rate, in a defined zone, without asking a seed company to add another universal coating. A researcher can compare recipes in the same field. A grower can reserve an expensive treatment for the acres where disease risk or crop value makes the arithmetic plausible.
The economics still have to survive a busy planting day. Added tanks, lines, controls and calibration create complexity. A missed window can cost more than an elegant prescription saves. The system must handle products consistently, target moving seed, avoid damaging flow and remain serviceable far from a factory technician. That operational burden is the first thing a serious buyer should test.
Proof measured in cartons
Seed Edge Ag offers a useful glimpse of how IPT's technology may be sold: not as abstract precision, but as an observable harvest comparison. Its public specialty-crop snapshots pair curated biological programs with POP-ST application and retain untreated areas for reference. In reported Salinas Valley comparisons, treated cauliflower strips produced 362 cartons versus 286 on a first harvest pass, and broccoli produced 758 cartons per acre versus 569. A celery comparison shifted a larger share of the treated block into the desired 18-count pack size.
Those are partner-published comparisons, not a universal forecast. Field, season, product and management change the result. Still, the reporting format is smart. A vegetable grower does not bank “application precision.” The grower banks cartons, timing and pack-out. By translating a technical system into the customer's unit of consequence, the joint venture makes a pilot easier to judge.
What another operator can copy
The most portable idea is not the nozzle. It is IPT's sequence: find a valuable decision made too early, move it closer to use, then build evidence in the buyer's language. The company also separates invention from scale. It protects the method, but recruits partners for equipment refinement, trials, input expertise and distribution. That keeps a small team focused on the narrow layer where it has an advantage.
A field-test recipe worth stealing
- Choose one crop, one treatment and one management question.
- Preserve a nearby untreated control under comparable conditions.
- Log calibration, application rate, downtime and product handling.
- Measure the outcome in saleable yield, quality or avoided cost.
- Scale only after the extra margin clears equipment and operating friction.
This approach also exposes weak products quickly. If a biological treatment cannot separate from a control when it is fresh, precisely placed and tested under a relevant prescription, delivery was probably not the only problem. The platform can become a filter as much as an applicator.
Where the idea breaks
Prescriptive treatment depends on meaningful variation. A uniform field with a simple, proven base treatment may not need another machine. A prescription built on poor data merely automates guesswork. Low-value crops or small acreages may not generate enough incremental margin to cover hardware, service and attention. Some products may be incompatible with the system's fluid handling, dose range or required environmental controls.
The best conditions are almost the reverse: visible field variability, costly or fragile treatments, strong agronomic data, reliable dealer support and a crop whose quality or yield pays for precision. Specialty vegetables provide an obvious proving ground because small changes in pack-out can carry immediate value. Broad-acre crops offer greater scale, but they also demand rugged equipment, fast logistics and repeatable economics.
A narrow place in a large market
IPT sits between three established worlds: seed treatment, precision planting and crop biologicals. It does not need to replace any of them. Conventional protection can remain on the seed; the planter keeps planting; a prescription adds only the product and rate justified for that location. That additive position is commercially useful because it asks partners and farmers to extend an existing workflow rather than abandon it.
The open question is execution at scale. Patents define a lane, partnerships supply machinery and access, and field comparisons create interest. Durable adoption will come from ordinary details: clean tanks, accurate doses, quick service, compatible products and a return visible after harvest. For a company founded around a seed's two-second fall, that is fitting. The ambition is broad, but the work remains precise.